We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
76
Revolution Medicines
RVMD
$38.4B
$56.5M 0.29%
580,677
-450,315
-44% -$45.5M
PFE icon
77
Pfizer
PFE
$141B
$56M 0.29%
1,992,586
+19,837
+1% +$528K
ROIV icon
78
Roivant Sciences
ROIV
$24.5B
$55.5M 0.29%
2,001,976
-488,450
-20% -$12.5M
SYK icon
79
Stryker
SYK
$122B
$54.9M 0.29%
167,146
+2,694
+2% +$967K
ZTS icon
80
Zoetis
ZTS
$31.9B
$54.2M 0.28%
458,854
-67,878
-13% -$8.39M
CRWD icon
81
CrowdStrike
CRWD
$202B
$53.9M 0.28%
552,524
-79,300
-13% -$8.4M
ASND icon
82
Ascendis Pharma A/S
ASND
$16.5B
$52.7M 0.27%
230,278
+43,338
+23% +$9.72M
AWK icon
83
American Water Works
AWK
$26.1B
$52.5M 0.27%
385,613
-9,097
-2% -$1.2M
ENSG icon
84
The Ensign Group
ENSG
$10.1B
$52.4M 0.27%
259,917
+188,679
+265% +$36.9M
DHR icon
85
Danaher
DHR
$142B
$52.3M 0.27%
275,951
-193,819
-41% -$41.3M
MDB icon
86
MongoDB
MDB
$26B
$52.2M 0.27%
213,067
+54,927
+35% +$18.4M
COST icon
87
Costco
COST
$415B
$50.7M 0.26%
50,860
+2,224
+5% +$2.17M
BMY icon
88
Bristol-Myers Squibb
BMY
$123B
$49.8M 0.26%
821,620
-85,094
-9% -$4.96M
MEDP icon
89
Medpace
MEDP
$15.1B
$49.6M 0.26%
103,349
+64,314
+165% +$32.9M
DIS icon
90
Walt Disney
DIS
$167B
$49.4M 0.26%
512,845
+21,026
+4% +$2.22M
PLD icon
91
Prologis
PLD
$138B
$49.2M 0.26%
371,966
+56,089
+18% +$7.49M
TRMB icon
92
Trimble
TRMB
$12.4B
$46.1M 0.24%
707,290
-34,464
-5% -$2.4M
BKNG icon
93
Booking.com
BKNG
$139B
$45.4M 0.24%
269,825
-212,950
-44% -$39.2M
RL icon
94
Ralph Lauren
RL
$22.4B
$45.3M 0.24%
131,593
+17,185
+15% +$6.11M
VEEV icon
95
Veeva Systems
VEEV
$32.1B
$45.2M 0.23%
257,459
+8,109
+3% +$1.59M
ADP icon
96
Automatic Data Processing
ADP
$102B
$44.7M 0.23%
219,936
-82,168
-27% -$18.8M
MDGL icon
97
Madrigal Pharmaceuticals
MDGL
$12.4B
$44.5M 0.23%
84,948
+21,042
+33% +$10.1M
C icon
98
Citigroup
C
$216B
$43.5M 0.23%
383,662
+40,632
+12% +$4.63M
BNTX icon
99
BioNTech
BNTX
$23.3B
$43.4M 0.23%
488,367
-116,549
-19% -$12M
MIRM icon
100
Mirum Pharmaceuticals
MIRM
$7.11B
$42.9M 0.22%
464,216
-105,374
-18% -$9.91M

Similar funds

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.